← Back to Clinical Trials
Recruiting NCT06719154

Evaluation of the Safety and Efficacy of Profhilo® Structura

Trial Parameters

Condition Skin Aging
Sponsor IBSA Farmaceutici Italia Srl
Study Type OBSERVATIONAL
Phase N/A
Enrollment 164
Sex ALL
Min Age 35 Years
Max Age 55 Years
Start Date 2024-09-09
Completion 2025-06
Interventions
Profhilo StructuraSham (No Treatment)

Brief Summary

Profhilo® Structura is composed of a buffered saline solution of high molecular weight (H-HA) and low molecular weight (L-HA) hyaluronic acid. The high- and low-molecular-weight HA used in the device is obtained by biofermentation and has not undergone chemical modification processes; this results in excellent tolerability of the product. In addition, the HA chains with different molecular weight present in Profhilo® Structura, thanks to a specific and patented treatment of the solution (NAHYCO® Hybrid Technology), interact with each other, giving Profhilo® Structura unique rheological properties that allow higher concentrations of HA to be administered at equal viscosity of the solution. The formulation based on HA with different molecular weight contained in Profhilo® Structura is based on the Hydrolift® Action system, the innovative approach aimed at combating the physiological decrease of HA in the skin, restoring hydration, elasticity and tone, synergistically associating deep hydration with the mechanical lifting action of the skin depression. Thanks to its rheological properties and cohesivity Profhilo® Structura is able to optimally spread and integrate into the interstitial spaces of the adipose tissue. Profhilo® Structura has the specific indication for adipose tissue restoration and is able to counteract facial volume loss.

Eligibility Criteria

Inclusion Criteria: 1. Healthy subjects 2. Male and Female subjects. 3. Age : between 35 and 55 year 4. Subject having given freely and expressly his/her informed consent obtained according to ISO 14155:2020 and Good Clinical Practice (GCP) 5. Only for treated group: Subject seeking aesthetic improvement for a corrective/filling action of natural and induced skin depressions 6. Women of childbearing potential must have a negative urine pregnancy test result at inclusion visit and must use a reliable method of contraception since at least 12 weeks and throughout the study. 7. Subject psychologically able to understand the information related to the investigation including possible risks and side effects. 8. Subject able to cooperate with the Investigator and to comply with the requirements of the entire investigation (including ability to attend all the planned investigation visits according to the time limits), based on investigator's judgement. 9. Subject agreeing to keep their usual

Related Trials